U.S. Selected Practice Recommendations for Contraceptive Use, 2024
Kathryn M. Curtis(National Center for Chronic Disease Prevention and Health Promotion), Steffanie Wright(Unknown), Megan Cohen(National Center for Chronic Disease Prevention and Health Promotion), Maura K. Whiteman(National Center for Chronic Disease Prevention and Health Promotion), Nisha Verma, Emily M Snyder(National Center for Chronic Disease Prevention and Health Promotion), Jessica Rodenhizer, Kendra Hatfield‐Timajchy(National Center for Chronic Disease Prevention and Health Promotion), Divya Dethier, Heather T. Gold, Katherine Kortsmit(National Center for Chronic Disease Prevention and Health Promotion), Lauren B. Zapata(National Center for Chronic Disease Prevention and Health Promotion), Gopika Krishna, Courtney C. Baker, Nathalie Kapp(World Health Organization), Marielle E. Meurice, Emma Halper, Antoinette T. Nguyen(University of Alberta), Naomi K. Tepper(National Center for Chronic Disease Prevention and Health Promotion), Sophia Garbarino, Stephanie Ramer
Cited by 120
Related Papers
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
|MMWR Recommendations and Reports|2016|1.5k
Medical methods for first trimester abortion
|Cochrane Database of Systematic Reviews|2011|288
Identification and Management of Eating Disorders in Children and Adolescents
|PEDIATRICS|2020|281
U.S. Medical Eligibility Criteria for Contraceptive Use, 2024
|MMWR Recommendations and Reports|2024|195
Abortion Surveillance — United States, 2019
|MMWR Surveillance Summaries|2021|141